The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
暂无分享,去创建一个
S. Bryan | M. Connock | E. Frew | C. Cummins | A. Fry-Smith | A. Po | J. Sandercock | B. Evans
[1] J. Kohyama,et al. Surveillance for fatal suspected adverse drug reactions in the UK , 2002, Archives of disease in childhood.
[2] A. G. Marson,et al. Remacemide for drug-resistant localization related epilepsy. , 2002, The Cochrane database of systematic reviews.
[3] P. Veggiotti,et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial , 2002, Epilepsy Research.
[4] J. Asconapé. Some Common Issues in the Use of Antiepileptic Drugs , 2002, Seminars in neurology.
[5] G. Anderson. Children Versus Adults: Pharmacokinetic and Adverse‐Effect Differences , 2002, Epilepsia.
[6] B. Bourgeois. Differential Cognitive Effects of Antiepileptic Drugs , 2002, Journal of child neurology.
[7] P. Chauvel,et al. Dose–response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy , 2002, Epilepsy Research.
[8] J. Arends,et al. Randomized Double‐blind Parallel‐group Study Comparing Cognitive Effects of a Low‐dose Lamotrigine with Valproate and Placebo in Healthy Volunteers , 2002, Epilepsia.
[9] J. Dunne,et al. AUStralian Study of Titration to Effect Profile of Safety (AUS‐STEPS): High‐Dose Gabapentin (Neurontin) in Partial Seizures , 2001, Epilepsia.
[10] K. Satoh,et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy [RETRACTED] , 2001, Neurology.
[11] M. Ueberall. Normal growth during lamotrigine monotherapy in pediatric epilepsy patients — a prospective evaluation of 103 children and adolescents , 2001, Epilepsy Research.
[12] J. Cramer,et al. The Short‐Term Impact of Adjunctive Tiagabine on Health‐Related Quality of Life , 2001, Epilepsia.
[13] R. Kuzniecky,et al. Comparative Cognitive Effects of Carbamazepine and Gabapentin in Healthy Senior Adults , 2001, Epilepsia.
[14] K. Meador,et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine , 2001, Neurology.
[15] A. Arzimanoglou,et al. Utilisation optimale de la lamotrigine en pratique clinique: Resultats d'une etude ouverte multicentrique dans l'epilepsie refractaire , 2001 .
[16] E A Harvey,et al. The teratogenicity of anticonvulsant drugs. , 2001, The New England journal of medicine.
[17] H. Meinardi,et al. Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures , 2001, Epilepsia.
[18] L. Lamoreaux,et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study. , 2001, Developmental medicine and child neurology.
[19] G. Coppola,et al. Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial , 2001, Epilepsy Research.
[20] J. Sackellares,et al. Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate , 2001, Epilepsy & Behavior.
[21] A. Eriksson,et al. The Effect of Lamotrigine on Epileptiform Discharges in Young Patients with Drug‐Resistant Epilepsy , 2001, Epilepsia.
[22] V. Biton,et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy , 2001, Neurology.
[23] N. Accornero,et al. Changes in Color Vision after a Single Dose of Vigabatrin or Carbamazepine in Healthy Volunteers , 2001, Clinical neuropharmacology.
[24] A. Biraben,et al. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. , 2000, Neurology.
[25] J. Wheless. Use of Topiramate in Childhood Generalized Seizure Disorders , 2000, Journal of child neurology.
[26] P. Levisohn. Safety and Tolerability of Topiramate in Children , 2000, Journal of child neurology.
[27] M. Frye,et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. , 2000, Journal of clinical psychopharmacology.
[28] P. Uldall,et al. Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study , 2000, Epilepsy Research.
[29] G. Mawer,et al. A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy , 2000, Seizure.
[30] O. Dulac,et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial , 2000, The Lancet.
[31] E. Perucca,et al. Add-On Lamotrigine Treatment in Children and Young Adults With Severe Partial Epilepsy: An Open, Prospective, Long-Term Study , 2000, Journal of child neurology.
[32] D. Walshaw,et al. Population based, prospective study of the care of women with epilepsy in pregnancy , 2000, BMJ : British Medical Journal.
[33] Hsiang-Yu Yu,et al. A Double‐Blind, Placebo‐Controlled Study of Topiramate in Adult Patients with Refractory Partial Epilepsy , 2000, Epilepsia.
[34] G. Pledger,et al. A Multicenter, Randomized Clinical Study to Evaluate the Effect on Cognitive Function of Topiramate Compared with Valproate as Add‐On Therapy to Carbamazepine in Patients with Partial‐Onset Seizures , 2000, Epilepsia.
[35] M. Brodie,et al. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure , 2000, Seizure.
[36] N. Earl,et al. Weight gain associated with valproate vs. lamotrigine monotherapy in patients with epilepsy: A randomized, double-blind comparative clinical trial , 2000, European Neuropsychopharmacology.
[37] R. Hogan,et al. Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin , 2000, Epilepsy Research.
[38] E. Shahar,et al. Visual impairment in children with epilepsy treated with vigabatrin , 2000, Annals of neurology.
[39] R. Mattson,et al. A comparison of four new antiepileptic medications , 2000, Seizure.
[40] Ron D. Hays,et al. Quality of life measures in epilepsy , 2000, Neurology.
[41] J. Bruni,et al. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study , 2000, Seizure.
[42] J. Bruni,et al. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy , 2000, Seizure.
[43] F. Balestrieri,et al. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels , 2000, Seizure.
[44] G. Montouris,et al. Nonfocal Generalized Tonic–Clonic Seizures: Response During Long‐Term Topiramate Treatment , 2000, Epilepsia.
[45] E. Wyllie,et al. Effectiveness, Tolerability, and Safety of Topiramate in Children with Partial‐Onset Seizures , 2000, Epilepsia.
[46] T. Glauser,et al. Topiramate in Lennox–Gastaut Syndrome: Open‐Label Treatment of Patients Completing a Randomized Controlled Trial , 2000, Epilepsia.
[47] R. Fisher,et al. Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop? , 1999, Neurology.
[48] M. Brodie,et al. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy , 1999, Epilepsy Research.
[49] A. Murro,et al. Differential Cognitive Effects of Carbamazepine and Gabapentin , 1999, Epilepsia.
[50] E. Perucca,et al. Induction of Ethinylestradiol and Levonorgestrel Metabolism by Oxcarbazepine in Healthy Women , 1999, Epilepsia.
[51] M. McLean. Gabapentin in the Management of Convulsive Disorders , 1999, Epilepsia.
[52] A. Beydoun. Monotherapy Trials with Gabapentin for Partial Epilepsy , 1999, Epilepsia.
[53] E. Kirveskari,et al. Lamotrigine Therapy in Juvenile Neuronal Ceroid Lipofuscinosis , 1999, Epilepsia.
[54] J. Bruni. Gabapentin as Adjunctive Therapy for Partial Seizures , 1999, Epilepsia.
[55] C. Dodrill,et al. Cognitive abilities and adjustment with gabapentin: results of a multisite study , 1999, Epilepsy Research.
[56] G. Pledger,et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures , 1999, Neurology.
[57] I. Leppik,et al. Safety of tiagabine: summary of 53 trials , 1999, Epilepsy Research.
[58] C. Dean,et al. Dose–Response Study of Vigabatrin as Add‐On Therapy in Patients with Uncontrolled Complex Partial Seizures , 1999, Epilepsia.
[59] Jullie W Pan,et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults , 1999, Neurology.
[60] M. Rowbotham,et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. , 1998, JAMA.
[61] G. Harding,et al. Visual electrophysiological effect of a GABA transaminase blocker , 1998, Documenta Ophthalmologica.
[62] M. Trimble,et al. Effects of gabapentin on cognition and quality of life in patients with epilepsy , 1998, Seizure.
[63] S. Pavlakis,et al. Valproate therapy: predisposition to bone fracture? , 1998, Pediatric neurology.
[64] J. McAuley,et al. Pharmacotherapeutic Issues for Women of Childbearing Age with Epilepsy , 1998, The Annals of pharmacotherapy.
[65] G. Baker,et al. Uptake and Costs of Care for Epilepsy: Findings from a U.K. Regional Study , 1998, Epilepsia.
[66] S. Noachtar,et al. Gabapentin and carbamazepine affect eye movements and posture control differently: A placebo-controlled investigation of acute CNS side effects in healthy volunteers , 1998, Epilepsy Research.
[67] J. Bruni. Outcome Evaluation of Gabapentin as Add-on Therapy for Partial Seizures , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[68] A. Sedman,et al. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol , 1998, Neurology.
[69] M. Knip,et al. Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsy , 1998, Annals of neurology.
[70] A. Fois,et al. Lamotrigine Treatment in Childhood Drug Resistant Epilepsy , 1998, Journal of child neurology.
[71] M. Brodie,et al. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures , 1998, Epilepsy Research.
[72] A. Beydoun,et al. Conversion to High Dose Gabapentin Monotherapy in Patients with Medically Refractory Partial Epilepsy , 1998, Epilepsia.
[73] A. Palmini,et al. Vigabatrin in refractory childhood epilepsy. The Brazilian multicenter study , 1997, Epilepsy Research.
[74] T. Nurmikko,et al. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial , 1997, Pain.
[75] J. Messenheimer,et al. 3-17-10 Clinical trial experience with lamotrigine (lamictal) in the management of adults with epilepsy , 1997, Journal of the Neurological Sciences.
[76] P. Czapiński,et al. 2-17-02 Open randomized comparative study of vigabatrin (VGB) and lamotrigine (LTG) efficacy in monotherapy of patients with drug-resistant epilepsy with partial complex seizures resistant to carbamazepine (CBZ) , 1997, Journal of the Neurological Sciences.
[77] G. Bergey,et al. Gabapentin monotherapy: I. An 8-day, double-blind, dose controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures , 1997, Neurology.
[78] G. Regesta,et al. 3-17-32 Vigabatrin vs carbamazepine monotherapy in newly diagnosed focal epileptics. A randomized response conditional cross-over study , 1997, Journal of the Neurological Sciences.
[79] R. Mann,et al. Safety of Long‐Term Lamotrigine in Epilepsy , 1997, Epilepsia.
[80] A. Pakarinen,et al. Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy , 1997, Seizure.
[81] E. Perucca,et al. A Double‐Blind, Placebo‐Controlled Study on the Effect of Vigabatrin on In Vivo Parameters of Hepatic Microsomal Enzyme Induction and on the Kinetics of Steroid Oral Contraceptives in Healthy Female Volunteers , 1997, Epilepsia.
[82] M. Connolly,et al. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. , 1997, Pediatric neurology.
[83] W. Rosenfeld,et al. Effect of Topiramate on the Pharmacokinetics of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol in Patients with Epilepsy , 1997, Epilepsia.
[84] O. Dulac,et al. Long-term safety and efficacy of lamotrigine (Lamictal®) in paediatric patients with epilepsy , 1997, Seizure.
[85] E. Faught. Efficacy of Topiramate as Adjunctive Therapy in Refractory Partial Seizures: United States Trial Experience , 1997, Epilepsia.
[86] E. Ben-Menachem. Clinical Efficacy of Topiramate as Add‐On Therapy in Refractory Partial Epilepsy: The European Experience , 1997, Epilepsia.
[87] P. Penovich,et al. Treatment With High Doses of Lamotrigine in Children and Adolescents With Refractory Seizures , 1997, Journal of child neurology.
[88] J. Herranz,et al. Add-On Vigabatrin in Children with Refractory Epilepsy , 1996 .
[89] L. Davis,et al. Valproate-associated weight gain: Potential relation to energy expenditure and metabolism in patients with epilepsy , 1996 .
[90] E. Ben-Menachem,et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy , 1996, Epilepsy Research.
[91] G. Regesta,et al. Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study , 1996, Epilepsy Research.
[92] P. Riekkinen,et al. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy , 1996, Epilepsy Research.
[93] E. Perucca,et al. Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine , 1996, Clinical pharmacokinetics.
[94] F. Matsuo,et al. Lamotrigine High‐Dose Tolerability and Safety in Patients with Epilepsy: A Double‐Blind, Placebo‐Controlled, Eleven‐Week Study , 1996, Epilepsia.
[95] M. Trimble,et al. The effects of vigabatrin on attention, concentration and mood: an investigation in healthy volunteers , 1996, Seizure.
[96] G. Pledger,et al. Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy , 1996, Epilepsia.
[97] G. Pledger,et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages , 1996, Neurology.
[98] E. Ben-Menachem,et al. Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures , 1996, Epilepsia.
[99] A. Herzog. Polycystic ovarian syndrome in women with epilepsy: Epileptic or iatrogenic? , 1996, Annals of neurology.
[100] M. Dam,et al. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy , 1996, Epilepsy Research.
[101] J. French,et al. A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures , 1996, Neurology.
[102] R. Nemire,et al. Weight gain and gabapentin therapy , 1995, The Annals of pharmacotherapy.
[103] N. Buchanan. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability , 1995, Seizure.
[104] F. Matsuo,et al. Lamotrigine: A six-month, placebo-controlled, safety and tolerance study , 1995 .
[105] Y. M. Hart,et al. Remission of epilepsy: results from the National General Practice Study of Epilepsy , 1995, The Lancet.
[106] A. Gnanasakthy,et al. Efficacy and Tolerability of Vigabatrin in Children with Refractory Partial Seizures: A Single‐Blind Dose‐Increasing Study , 1995, Epilepsia.
[107] S. Schachter. Tiagabine Monotherapy in the Treatment of Partial Epilepsy , 1995, Epilepsia.
[108] D. Chadwick,et al. Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial , 1995, Epilepsy Research.
[109] N. Sopranzi,et al. [Lamotrigine: first experience in Italy]. , 1995, La Clinica terapeutica.
[110] E. Ben-Menachem,et al. DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 400 MG/DAY TOPIRAMATE AS ADD-ON THERAPY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY , 1995 .
[111] M. Brodie,et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy , 1995, The Lancet.
[112] C. Dodrill,et al. Effects of Differing Dosages of Vigabatrin (Sabril) on Cognitive Abilities and Quality of Life in Epilepsy , 1995, Epilepsia.
[113] A. Richens. Safety of Lamotrigine , 1994, Epilepsia.
[114] D. Treiman,et al. Efficacy and Tolerance of Long‐Term, High‐Dose Gabapentin: Additional Observations , 1994, Epilepsia.
[115] M. Brodie,et al. Vigabatrin and lamotrigine in refractory epilepsy. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[116] D. Lindhout,et al. Teratogenic Effects of Antiepileptic Drugs: Implications for the Management of Epilepsy in Women of Childbearing Age , 1994, Epilepsia.
[117] O. Dulac,et al. Lamotrigine in Treatment of 120 Children with Epilepsy , 1994, Epilepsia.
[118] P. Curatolo. Vigabatrin for Refractory Partial Seizures in Children with Tuberous Sclerosis , 1994, Neuropediatrics.
[119] R. Mattson,et al. Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial , 1994, Epilepsia.
[120] C. Loeb,et al. Vigabatrin in chronic epilepsy: a 7-year follow-up study of responder patients , 1993, Seizure.
[121] C. Dodrill,et al. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy , 1993, Neurology.
[122] A. Pakarinen,et al. Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy , 1993 .
[123] F. Matsuo,et al. Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures , 1993, Neurology.
[124] David F. Smith,et al. Seizure Severity and the Quality of Life , 1993, Epilepsia.
[125] M. Brodie,et al. Adjuvant Vigabatrin in Refractory Epilepsy: A Ceiling to Effective Dosage in Individual Patients? , 1993, Epilepsia.
[126] S. Berkovic,et al. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[127] O. Kristensen,et al. Therapeutic experiences with 947 epileptic out‐patients in oxcarbazepine treatment , 1993, Acta neurologica Scandinavica.
[128] J. Herranz,et al. Platelet GABA-transaminase in epileptic children: influence of epilepsy and anticonvulsants , 1993, Epilepsy Research.
[129] B. Weatherley,et al. Carbamazepine and Lamotrigine in Healthy Volunteers: Relevance to Early Tolerance and Clinical Trial Dosage , 1993, Epilepsia.
[130] A. Gnanasakthy,et al. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy , 1992, The Italian Journal of Neurological Sciences.
[131] E. Perucca,et al. Six‐year follow‐up study on the efficacy and safety of vigabatrin in patients with epilepsy , 1992, Acta neurologica Scandinavica.
[132] E. Valdizán,et al. γ‐Vinyl GABA (Vigabatrin): Relationship Between Dosage, Plasma Concentrations, Platelet GABA‐Transaminase Inhibition, and Seizure Reduction in Epileptic Children , 1992, Epilepsia.
[133] J. Jolkkonen,et al. Absence of interaction between oxcarbazepine and erythromycin , 1992, Acta neurologica Scandinavica.
[134] R. Fincham,et al. Phenytoin Pharmacokinetics: Before and After Folic Acid Administration , 1992, Epilepsia.
[135] T. Halonen,et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up , 1992, Epilepsy Research.
[136] R. Ramsay,et al. Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy , 1991, Epilepsy Research.
[137] O. Dulac,et al. Vigabatrin in Childhood Epilepsy , 1991, Journal of child neurology.
[138] J. Partanen,et al. Randomized Controlled Pilot Study of Vigabatrin Versus Carbamazepine Monotherapy in Newly Diagnosed Patients With Epilepsy: An Interim Report , 1991, Journal of child neurology.
[139] A. Ylinen,et al. Double‐Blind Study of Gabapentin in the Treatment of Partial Seizures , 1991, Epilepsia.
[140] A. Richens,et al. Overview of the Clinical Efficacy of Lamotrigine , 1991, Epilepsia.
[141] R. Mattson,et al. Multicenter long‐term safety and efficacy study of vigabatrin for refractory complex partial seizures , 1991, Neurology.
[142] R. Meadow. Anticonvulsants in pregnancy. , 1991, Archives of disease in childhood.
[143] D. Back,et al. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. , 1990, British journal of clinical pharmacology.
[144] P. Loiseau,et al. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures , 1990, Epilepsy Research.
[145] D. Back,et al. The interaction of phenytoin and carbamazepine with oral contraceptive steroids , 1990 .
[146] O. Dulac,et al. Vigabatrin in the Treatment of Childhood Epilepsies: A Single‐Blind Placebo‐Controlled Study , 1989, Epilepsia.
[147] G. Goodwin,et al. Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial Seizures , 1989, Epilepsia.
[148] J. Partanen,et al. Electrophysiologic Effects of γ‐Vinyl GABA and Carbamazepine , 1989 .
[149] C. Loeb,et al. Vigabatrin in complex partial seizures: a long-term study , 1989, Epilepsy Research.
[150] R. Mattson,et al. A multicentre study of vigabatrin for drug-resistant epilepsy. , 1989, British journal of clinical pharmacology.
[151] J. Aicardi,et al. Vigabatrin in the treatment of epilepsy in children. , 1989, British journal of clinical pharmacology.
[152] M. Dam,et al. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. , 1989, British journal of clinical pharmacology.
[153] W. Burr,et al. Double-blind placebo-controlled trial with flunarizine in therapy-resistant epileptic patients. , 1988, Clinical neuropharmacology.
[154] A. Ylinen,et al. Double‐Blind Dose Reduction Study of Vigabatrin in Complex Partial Epilepsy , 1987, Epilepsia.
[155] T. Halonen,et al. Comparison of oxcarbazepine and carbamazepine: a double-blind study , 1987, Epilepsy Research.
[156] Stewart Cf,et al. Effect of maturation on drug disposition in pediatric patients. , 1987 .
[157] L. Blumhardt,et al. Gabapentin as an antiepileptic drug in man. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[158] R. Mattson,et al. Vigabatrin for refractory complex partial seizures , 1987, Neurology.
[159] M. Haukkamaa. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment. , 1986, Contraception.
[160] V. Odlind,et al. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants. , 1986, Contraception.
[161] K. Reinikainen,et al. Substitution of diphenylhydantoin by oxcarbazepine or carbamazepine: double‐blind study , 1984 .
[162] M. Dam,et al. Gamma‐vinyl‐GABA: A single‐blind trial in patients with epilepsy , 1983, Acta neurologica Scandinavica.
[163] M. Painter,et al. Phenobarbital and diphenylhydantoin levels in neonates with seizures. , 1978, The Journal of pediatrics.
[164] C. Palmieri,et al. Teratogenic Potential of the Newer Antiepileptic Drugs , 2002, CNS drugs.
[165] G. Kluger,et al. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[166] T. Glauser,et al. 325 Effect of topiramate on height and weight of children with partial-onset seizures , 1999 .
[167] M. Trimble,et al. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs , 1999, Seizure.
[168] B. Uthman,et al. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. , 1998, Archives of neurology.
[169] T. Feuerstein,et al. Long-term safety and efficacy of gabapentin (neurontin) as add-on therapy in patients with refractory partial seizures , 1995 .
[170] M. Brodie,et al. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. , 1994, British journal of clinical pharmacology.
[171] R. Michelucci,et al. Long-term follow-up study of vigabatrin in the treatment of refractory epilepsy , 1994 .
[172] M. Eldon. Lack of effect of gabapentin on the pharmacokinetics of a norethindrone acetate/ethinyl estradiol-containing oral contraceptive , 1993 .
[173] R. Michelucci,et al. Single-blind, placebo-controlled dose-modification study of vigabatrin in refractory epileptic patients , 1992 .
[174] D. Faulds,et al. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. , 1992, Drugs.
[175] M. Sillanpää,et al. Oxcarbazepine (GP 47 680) in the treatment of intractable seizures. , 1988, Acta paediatrica Hungarica.
[176] R. Michelucci,et al. Vigabatrin in the treatment of drug-resistant epilepsy: Short-term results of 2 placebo - controlled trials , 1988 .